Ortin Laboratories Reports Decline in Profitability for Q1 2024
Ortin Laboratories, a microcap pharmaceutical company, reported negative financial results for the quarter ending March 2024. The company's PBT and PAT saw significant decreases compared to the previous year, and its operating profit was at its lowest in the last five quarters. This may raise concerns for investors and stakeholders.
Ortin Laboratories, a microcap pharmaceutical company, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a "Strong Sell" rating by MarketsMOJO.
According to the financial report, Ortin Labs. has experienced negative performance in the quarter, with a score that has remained the same for the past three months. This is a cause for concern for investors and stakeholders.
The company's Profit Before Tax less Other Income (PBT) for the quarter was at Rs -3.18 crore, a significant decrease of -1666.67% compared to the same quarter last year. This trend is expected to continue in the near term, indicating a negative outlook for the company's profitability.
Similarly, the Profit After Tax (PAT) for the quarter was at Rs -4.14 crore, a decrease of -2200.0% compared to the previous year. This is also a worrying trend for the company's financial health.
The Operating Profit (PBDIT) for the quarter was at its lowest in the last five quarters, at Rs -3.06 crore. This indicates a negative trend in the company's operating performance in the near term.
Overall, the financial results for the quarter ending March 2024 show a decline in profitability for Ortin Laboratories. The company's Earnings per Share (EPS) for the quarter was also at its lowest in the last five quarters, at Rs -5.09. This is a cause for concern for shareholders as it indicates a decrease in earnings.
Investors and stakeholders should closely monitor the company's financial performance in the coming quarters to make informed decisions about their investments.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
